Xiaoping Mm Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xiaoping Mm Li has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Bin-Hua Qin
South-Central University for Nationalities
1 shared publicationLe Li
Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China
1 shared publicationLinjuan Shi
School of Medical Technology, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China
1 shared publicationMing Sun
College of Acu-Moxibustion and Massage, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China
1 shared publication- Qiang Wang
Combination of Acupuncture and Medicine Innovation Research Center, Shaanxi University of Chinese Medicine, Xianyang, China
1 shared publication Qiao-Yu Yuan
Wuhan Polytechnic
1 shared publication
Latest Publications
- Open Access
- 17 July 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (29) , e49799
A bibliometric analysis of research trends and mechanisms of olfactory dysfunction in Alzheimer’s diseases from 2008 to 2024
Background: Olfactory dysfunction (OD) and Alzheimer disease (AD) represent significant global public health challenges. Growing evidence underscores the need to clarify the neuropathological mechanisms underlying their association. Our study intends to analyze global research trends and overlapping molecular mechanisms underlying OD and AD. Methods: Reviews and articles on OD and AD published between 2008 and 2024 were extracted from the Web of Science Core Collection. CiteSpace and VOSviewer were applied to for the analysis and visualization of the publication outputs, as well as the distribution of countries/regions, institutions and authors, the journals output, keywords co-occurrence, and reference citations. Molecular targets and associated pathways were investigated by GeneCards, STRING, and Metascape databases. Results: One thousand nine hundred sixteen publications were identified, demonstrating steady growth in research output across 7006 institutions from 398 countries. The USA emerged as the top contributor, excelling in both publication output and citation impact. The University of Pennsylvania, University of California San Francisco, and Chinese Academy of Sciences stood out as the top influential institutions. Among 10,476 authors, Thomas Hummel from Technische Universität Dresden, Germany, emerged as the most prominent scholar. In terms of journals, Journal of Alzheimer’s Disease leaded in publications in this field. Keywords including “Alzheimer’s disease,” “olfactory bulb,” and “cognitive impairment” represent the current research focuses. A total of 1779 overlapping genes were identified between OD and AD. ACTB, AKT1, TP53, CTNNB1 , and INS were identified as the most central regulatory genes. Enrichment analyses revealed involvement in PI3K-Akt, mitogen-activated protein kinases, and cyclic adenosine monophosphate signaling pathways, as well as biological functions related to signaling receptor activator activity, growth factor activity, and cytokine activity. Conclusion: Our study uncovers the dynamic research trends on OD and AD, while we further identified shared molecular mechanisms underlying these 2 disorders. Early olfactory risk assessment, diagnosis, and intervention may serve as critical components in the prevention and management in AD.
- 17 July 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (29) , e49799
Open AccessA bibliometric analysis of research trends and mechanisms of olfactory dysfunction in Alzheimer’s diseases from 2008 to 2024
Background: Olfactory dysfunction (OD) and Alzheimer disease (AD) represent significant global public health challenges. Growing evidence underscores the need to clarify the neuropathological mechanisms underlying their association. Our study intends to analyze global research trends and overlapping molecular mechanisms underlying OD and AD. Methods: Reviews and articles on OD and AD published between 2008 and 2024 were extracted from the Web of Science Core Collection. CiteSpace and VOSviewer were applied to for the analysis and visualization of the publication outputs, as well as the distribution of countries/regions, institutions and authors, the journals output, keywords co-occurrence, and reference citations. Molecular targets and associated pathways were investigated by GeneCards, STRING, and Metascape databases. Results: One thousand nine hundred sixteen publications were identified, demonstrating steady growth in research output across 7006 institutions from 398 countries. The USA emerged as the top contributor, excelling in both publication output and citation impact. The University of Pennsylvania, University of California San Francisco, and Chinese Academy of Sciences stood out as the top influential institutions. Among 10,476 authors, Thomas Hummel from Technische Universität Dresden, Germany, emerged as the most prominent scholar. In terms of journals, Journal of Alzheimer’s Disease leaded in publications in this field. Keywords including “Alzheimer’s disease,” “olfactory bulb,” and “cognitive impairment” represent the current research focuses. A total of 1779 overlapping genes were identified between OD and AD. ACTB, AKT1, TP53, CTNNB1 , and INS were identified as the most central regulatory genes. Enrichment analyses revealed involvement in PI3K-Akt, mitogen-activated protein kinases, and cyclic adenosine monophosphate signaling pathways, as well as biological functions related to signaling receptor activator activity, growth factor activity, and cytokine activity. Conclusion: Our study uncovers the dynamic research trends on OD and AD, while we further identified shared molecular mechanisms underlying these 2 disorders. Early olfactory risk assessment, diagnosis, and intervention may serve as critical components in the prevention and management in AD.
- Open Access
- 19 November 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (46) , e27195
Touching-bone acupuncture in the treatment of chronic pain
Background: Chronic pain is the most common disease in the world, which lead the patients to suffer the disability both physically and psychologically. The chronic pain can affects the patients to work, socialize, sleep and can lead to depressive illness, decreased motivation, and a reduction in physical activity. Acupuncture is a promising treatment for the chronic pain which has a long history of use in China. This protocol aims to assess the effectiveness and safety of touching periosteum acupuncture therapy on patients with chronic pain. Methods: Randomized controlled trial literatures which include touching periosteum acupuncture therapy for treating chronic pain will be searched from 8 electronic databases including China Biology Medicine disc, VIP database, WanFang database, China National Knowledge Infrastructure, PubMed, Cochrane Library, Excerpt Medical Database, and Web of Science. The language will be restricted to Chinese and English. The primary outcome is to measure the relief of the pain by Visual Analogue Scale. Two or 3 reviewers will conduct the study selection, data extraction and the evaluation of the risk of bias. RevMan software (V.5.3) will be used to perform the assessment of the risk of bias and data synthesis. Results: From this study, we will confirm the effectiveness of safety of in the treatment of chronic pain. Conclusions: We will ascertain the effectiveness of safety of touching periosteum acupuncture therapy in the treatment of chronic pain, to provide evidence to guide touching periosteum acupuncture therapy for patients with chronic pain in the future. Ethics and dissemination: Ethics approval will not be necessary, because the included publications in our study are all from published articles. This systematic review will be published in a peer-reviewed journal or conference report to provide a reference in this field. Trial registration: CRD42021243387.
- 19 November 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (46) , e27195
Open AccessTouching-bone acupuncture in the treatment of chronic pain
Background: Chronic pain is the most common disease in the world, which lead the patients to suffer the disability both physically and psychologically. The chronic pain can affects the patients to work, socialize, sleep and can lead to depressive illness, decreased motivation, and a reduction in physical activity. Acupuncture is a promising treatment for the chronic pain which has a long history of use in China. This protocol aims to assess the effectiveness and safety of touching periosteum acupuncture therapy on patients with chronic pain. Methods: Randomized controlled trial literatures which include touching periosteum acupuncture therapy for treating chronic pain will be searched from 8 electronic databases including China Biology Medicine disc, VIP database, WanFang database, China National Knowledge Infrastructure, PubMed, Cochrane Library, Excerpt Medical Database, and Web of Science. The language will be restricted to Chinese and English. The primary outcome is to measure the relief of the pain by Visual Analogue Scale. Two or 3 reviewers will conduct the study selection, data extraction and the evaluation of the risk of bias. RevMan software (V.5.3) will be used to perform the assessment of the risk of bias and data synthesis. Results: From this study, we will confirm the effectiveness of safety of in the treatment of chronic pain. Conclusions: We will ascertain the effectiveness of safety of touching periosteum acupuncture therapy in the treatment of chronic pain, to provide evidence to guide touching periosteum acupuncture therapy for patients with chronic pain in the future. Ethics and dissemination: Ethics approval will not be necessary, because the included publications in our study are all from published articles. This systematic review will be published in a peer-reviewed journal or conference report to provide a reference in this field. Trial registration: CRD42021243387.
- 1 March 2017
- Published by Springer Nature in Chemistry of Natural Compounds
- Vol. 53 (2) , 211-214
A New Biphenanthrene Glucoside with Cytotoxic Activity from Cremastra appendiculata
- 1 March 2017
- Published by Springer Nature in Chemistry of Natural Compounds
- Vol. 53 (2) , 211-214
A New Biphenanthrene Glucoside with Cytotoxic Activity from Cremastra appendiculata